Survival analysis indicated TRPS1 high expression was significantly associated with better RFS in all BC patients, hormone sensitive and Her-2 positive BC, but not in ER negative, Her-2 negative or basal-like subtypes, which implied that TRPS1 might act as a tumor suppressor in BC. This evidence concerns the gene ESR1 and neoplasm.